DeepCeutix provides an AI-powered co-scientist platform, DEEP C, that accelerates pharmaceutical formulation and regulatory processes. It combines computational chemistry with validated AI agents to reduce development timelines.
DeepCeutix has developed DEEP C, an AI-powered co-scientist platform designed to accelerate pharmaceutical formulation from early research through regulatory filing. The platform utilizes specialist agents grounded in authoritative scientific and regulatory corpora, including FDA, EMA, and ICH data. To ensure accuracy and prevent hallucinations, the system incorporates a proprietary constraint layer called Reality Anchor, which binds AI outputs to thermodynamics and regulatory requirements. The technology is built on peer-reviewed research and is engineered to support GAMP 5 principles and 21 CFR Part 11 compliance, providing immutable audit trails and full traceability for research activities.
This platform addresses the challenges of Eroom's Law by significantly reducing formulation timelines, allowing pharmaceutical teams to streamline processes such as bioavailability enhancement, stability optimization, and regulatory documentation. By integrating computational chemistry with pharmaceutical science, DeepCeutix enables teams to automate complex tasks ranging from solid dispersion design to patent landscape analysis and environmental risk assessments. The solution is designed to support the entire product lifecycle, helping organizations maintain data integrity and patient safety while preparing R&D data for automated regulatory compliance.